Untargeted plasma metabolomics reveals metabolite alterations and pathway perturbations in gestational diabetes mellitus
PLOS One · 19.11.2026 · 21 (11) · e0362854
DOI: 10.1371/journal.pone.0362854 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 19.11.2026. Verfasst von Kornpatchara Chaiyachate und 7 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Systems Research Institute, Faculty of Associated Medical Sciences, Khon Kaen University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objectives
Gestational diabetes mellitus (GDM) is defined as glucose intolerance first detected during pregnancy and is associated with adverse maternal and neonatal outcomes. Metabolomics provides a system-level approach to characterize metabolic alterations associated with gestational insulin resistance. This study aimed to identify plasma metabolite differences between women with GDM and normal glucose tolerance (NGT) and to evaluate the discriminatory performance of a metabolite-based panel.
Methods
Plasma samples from 270 pregnant women (169 GDM and 101 NGT) were analyzed using an untargeted 1 H nuclear magnetic resonance ( 1 H NMR)–based metabolomics approach. Differential metabolites were identified using univariate, followed by multivariate modeling and regression adjustment for maternal age and pre-pregnancy body mass index. Discriminatory performance was evaluated using Random Forest (RF), Partial Least Squares–Discriminant Analysis (PLS-DA), and Linear Support Vector Machine (Linear-SVM) models with Receiver Operating Characteristic curve analysis. Pathway enrichment analyses were performed using KEGG and SMPDB, and disease-based enrichment was assessed using HMDB.
Results
Among 31 identified metabolites, 14 differed significantly between GDM and NGT. Integration of univariate and multivariate analyses prioritized nine metabolites—acetone, citrate, glucose, succinate, glycine, 3-hydroxybutyrate, leucine, phenylalanine, and the CH = CH bond of unsaturated lipids—that remained independently associated with GDM after covariate adjustment. All nine metabolites were elevated in the GDM group. A nine-metabolite panel achieved an area under the curve (AUC) of 0.76 (95% CI: 0.70–0.81) using the RF model. Pathway enrichment identified valine, leucine, and isoleucine biosynthesis and ketone body metabolism as significantly enriched pathways. HMDB-based disease enrichment showed overlap with preeclampsia-related metabolic signatures.
Conclusion
Untargeted 1 H NMR metabolomics, combined enrichment analyses, identified coordinated metabolic disturbances in GDM involving amino acid and ketone body metabolism. A nine-metabolite panel demonstrated moderate discriminative performance and provides mechanistic insight into GDM-associated metabolic adaptations, supporting their potential utility for future biomarker validation and translational studies.
Förderung
- Health Systems Research Institute
- Faculty of Associated Medical Sciences, Khon Kaen University
Zitieren
APA
Chaiyachate, K., Pongsamakthai, M., Jamnongkan, W., Phetcharaburanin, J., Sawatjui, N., Kraiklang, R., Charoensri, S., & Jusakul, A. (2026). Untargeted plasma metabolomics reveals metabolite alterations and pathway perturbations in gestational diabetes mellitus. PLOS One, 21(11), e0362854. https://doi.org/10.1371/journal.pone.0362854
Vancouver
Chaiyachate K, Pongsamakthai M, Jamnongkan W, Phetcharaburanin J, Sawatjui N, Kraiklang R, et al. Untargeted plasma metabolomics reveals metabolite alterations and pathway perturbations in gestational diabetes mellitus. PLOS One. 2026;21(11):e0362854. doi:10.1371/journal.pone.0362854
BibTeX
@article{Chaiyachate2026,
author = {Chaiyachate, Kornpatchara and Pongsamakthai, Manasicha and Jamnongkan, Wassana and Phetcharaburanin, Jutarop and Sawatjui, Nopporn and Kraiklang, Ratthaphol and Charoensri, Suranut and Jusakul, Apinya},
title = {Untargeted plasma metabolomics reveals metabolite alterations and pathway perturbations in gestational diabetes mellitus},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0362854},
doi = {10.1371/journal.pone.0362854}
}
EUVIMED